Regeneron Pharmaceuticals (REGN) Net Income Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.08% |
| Dec 31, 2025 | -7.97% |
| Sep 30, 2025 | 8.91% |
| Jun 30, 2025 | -2.84% |
| Mar 31, 2025 | 12.01% |
| Dec 31, 2024 | -20.86% |
| Sep 30, 2024 | 33.02% |
| Jun 30, 2024 | 47.90% |
| Mar 31, 2024 | -11.71% |
| Dec 31, 2023 | -3.13% |
| Sep 30, 2023 | -23.40% |
| Jun 30, 2023 | 13.65% |
| Mar 31, 2023 | -15.99% |
| Dec 31, 2022 | -46.29% |
| Sep 30, 2022 | -19.39% |
| Jun 30, 2022 | -72.50% |
| Mar 31, 2022 | -12.71% |
| Dec 31, 2021 | 93.96% |
| Sep 30, 2021 | 93.82% |
| Jun 30, 2021 | 245.36% |
| Mar 31, 2021 | 78.55% |
| Dec 31, 2020 | 45.10% |
| Sep 30, 2020 | 25.76% |
| Jun 30, 2020 | 364.68% |
| Mar 31, 2020 | 35.46% |
| Dec 31, 2019 | -3.46% |
| Sep 30, 2019 | 12.59% |
| Jun 30, 2019 | -64.98% |
| Mar 31, 2019 | -3.54% |
| Dec 31, 2018 | 372.83% |
| Sep 30, 2018 | 53.15% |
| Jun 30, 2018 | 42.21% |
| Mar 31, 2018 | 92.02% |
| Dec 31, 2017 | -31.44% |
| Sep 30, 2017 | 46.64% |
| Jun 30, 2017 | 97.61% |
| Mar 31, 2017 | 37.24% |
| Dec 31, 2016 | 63.29% |
| Sep 30, 2016 | 25.86% |
| Jun 30, 2016 | 0.81% |
| Mar 31, 2016 | 138.60% |
| Dec 31, 2015 | 208.63% |
| Sep 30, 2015 | 152.35% |
| Jun 30, 2015 | 102.01% |
| Mar 31, 2015 | 11.30% |
| Dec 31, 2014 | -265.55% |
| Sep 30, 2014 | -41.00% |
| Jun 30, 2014 | 10.27% |
| Mar 31, 2014 | -30.92% |
| Dec 31, 2013 | -81.68% |
| Sep 30, 2013 | -26.20% |
| Jun 30, 2013 | 13.86% |
| Mar 31, 2013 | 748.63% |
| Dec 31, 2012 | 980.11% |
| Sep 30, 2012 | 407.01% |
| Jun 30, 2012 | 222.78% |
| Mar 31, 2012 | 126.82% |
| Dec 31, 2011 | -266.12% |
| Sep 30, 2011 | -84.10% |
| Jun 30, 2011 | -145.37% |
| Mar 31, 2011 | -42.35% |
| Dec 31, 2010 | 64.06% |
| Sep 30, 2010 | -3,237.44% |
| Jun 30, 2010 | -70.53% |